Literature DB >> 2358196

Changes in urethral cytology following estrogen administration.

A Bergman1, M M Karram, N N Bhatia.   

Abstract

Estrogen vaginal cream was given to 10 postmenopausal women with a diagnosis of genuine stress urinary incontinence. Clinical evaluation and urethral cytology from the midurethra were performed before and after 6 weeks of estrogen treatment. A favorable clinical response was obtained in 50% of the treated patients, in whom signs and symptoms of incontinence disappeared or significantly improved, by subjective and objective evaluation. Cytologic changes at the midurethra correlated well with clinical response to estrogens. Patients with a favorable response to treatment showed a positive 'maturation index' of squamous epithelium, changing towards more intermediate and superficial cells, and less transitional cells (p less than 0.05). Patients with a poor clinical response to estrogens had no significant change in urethral cytology after 6 weeks of therapy. Our results suggest that improvement or cure of stress incontinence after estrogen administration in postmenopausal women is achieved by affecting the 'urethral mucosal factor'.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358196     DOI: 10.1159/000293384

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  The effect of ultralow-dose transdermal estradiol on urinary incontinence in postmenopausal women.

Authors:  L Elaine Waetjen; Jeanette S Brown; Eric Vittinghoff; Kristine E Ensrud; JoAnn Pinkerton; Robert Wallace; Judith L Macer; Deborah Grady
Journal:  Obstet Gynecol       Date:  2005-11       Impact factor: 7.661

Review 2.  Economics of lower urinary tract symptoms (LUTS) in older people.

Authors:  U Azam; M Castleden; D Turner
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

3.  Does the menstrual cycle influence cystometry?

Authors:  S Shimonovitz; A K Monga; S L Stanton
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1997

4.  Postmenopausal hormone therapy: does it cause incontinence?

Authors:  Jody E Steinauer; L Elaine Waetjen; Eric Vittinghoff; Leslee L Subak; Stephen B Hulley; Deborah Grady; Feng Lin; Jeanette S Brown
Journal:  Obstet Gynecol       Date:  2005-11       Impact factor: 7.661

5.  Association of change in estradiol to lower urinary tract symptoms during the menopausal transition.

Authors:  Manish Gopal; Mary D Sammel; Lily A Arya; Ellen W Freeman; Hui Lin; Clarisa Gracia
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

6.  Immunohistochemical detection of estrogen and progesterone receptors in the normal urinary bladder and in pseudomembranous trigonitis.

Authors:  D Pacchioni; A Revelli; G Casetta; P Cassoni; P Piana; A Tizzani; G Bussolati; M Massobrio
Journal:  J Endocrinol Invest       Date:  1992-11       Impact factor: 4.256

Review 7.  Hormone-dependent aging problems in women.

Authors:  Byung Hwa Jung; Myung Jae Jeon; Sang Wook Bai
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

8.  Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Authors:  Shahla H Al-Saqi; Kerstin Uvnäs-Moberg; Aino F Jonasson
Journal:  Post Reprod Health       Date:  2015-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.